HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 287/4/H1868    most recent 00241.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (13) Citing Articles via Google Scholar Google Scholar Articles by Wang, Y. Articles by Wang, D. H. Search for Related Content PubMed PubMed Citation Articles by Wang, Y. Articles by Wang, D. H.

Prevention of endothelin-1-induced increases in blood pressure: role of endogenous CGRP

Department of Medicine and Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan 48824

Submitted 11 March 2004 ; accepted in final form 13 June 2004

To determine the role of endothelin-1 (ET-1) and its receptors in the regulation of calcitonin gene-related peptide (CGRP) release, male Wistar rats were divided into six groups and subjected to the following treatments for 1 wk with or without ABT-627 (an ET_A receptor antagonist, 5 mg·kg^–1·day^–1 in drinking water) or A-192621 (an ET_B-receptor antagonist, 30 mg·kg^–1·day^–1 by oral gavage): control (Con), ET-1 (5 ng·kg^–1·min^–1 iv), Con + ABT-627, Con + A-192621, ET-1 + ABT-627, and ET-1 + A-192621. Baseline mean arterial pressure (MAP, mmHg) was higher (P < 0.05) in Con + A-192621 (122 ± 4) and ET-1 + A-192621 (119 ± 4) groups compared with Con (104 ± 6), ET1 (106 ± 3), Con + ABT-627 (104 ± 3), and ET1 + ABT-627 (100 ± 3) groups. Intravenous administration of CGRP_8–37 (a CGRP receptor antagonist, 1 mg/kg) increased MAP (P < 0.05) in ET-1 (13 ± 1), Con + A-192621 (12 ± 1), and ET-1 + A-192621 (15 ± 3) groups compared with Con (4 ± 1), Con-ABT-627 (4 ± 1), and ET-1 + ABT-627 (5 ± 1) groups. Plasma CGRP levels (in pg/ml) were increased (P < 0.05) in ET-1 (57.5 ± 6.1), Con + A-192621 (53.9 ± 3.4), and ET-1 + A-192621 (60.4 ± 3.0) groups compared with Con (40.4 ± 1.6), Con + ABT-627 (40.0 ± 2.9), and ET-1 + ABT-627 (42.6 ± 1.9) groups. Plasma ET-1 levels (in pg/ml) were higher (P < 0.05) in ET-1 (2.8 ± 0.2), ET-1 + ABT-627 (3.2 ± 0.4), Con + A-192621 (3.3 ± 0.4), and ET-1 + A-192621 (4.6 ± 0.3) groups compared with Con (1.1 ± 0.2) and Con-ABT-627 (1.3 ± 0.2) groups. Therefore, our data show that ET-1 infusion leads to increased CGRP release via activation of the ET_A receptor, which plays a compensatory role in preventing ET-1-induced elevation in blood pressure.

endothelin receptor; calcitonin gene-related peptide

This article has been cited by other articles:

				C. Xie, J. R. Sachs, and D. H. Wang Interdependent Regulation of Afferent Renal Nerve Activity and Renal Function: Role of Transient Receptor Potential Vanilloid Type 1, Neurokinin 1, and Calcitonin Gene-Related Peptide Receptors J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 751 - 757. [Abstract] [Full Text] [PDF]

				Y. Wang, M. Novotny, V. Quaiserova-Mocko, G. M. Swain, and D. H. Wang TRPV1-mediated protection against endotoxin-induced hypotension and mortality in rats Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1517 - R1523. [Abstract] [Full Text] [PDF]

				J. G. R. De Mey, R. Megens, and G. E. Fazzi Functional Antagonism between Endogenous Neuropeptide Y and Calcitonin Gene-Related Peptide in Mesenteric Resistance Arteries J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 930 - 937. [Abstract] [Full Text] [PDF]

				Y. Zhou, S. Mitra, S. Varadharaj, N. Parinandi, J. L. Zweier, and N. A. Flavahan Increased Expression of Cyclooxygenase-2 Mediates Enhanced Contraction to Endothelin ETA Receptor Stimulation in Endothelial Nitric Oxide Synthase Knockout Mice Circ. Res., June 9, 2006; 98(11): 1439 - 1445. [Abstract] [Full Text] [PDF]

				Y. Wang, A. F. Chen, and D. H. Wang ETA receptor blockade prevents renal dysfunction in salt-sensitive hypertension induced by sensory denervation Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2005 - H2011. [Abstract] [Full Text] [PDF]

				Z. Xia, K.-H. Kuo, D. V. Godin, M. J. Walker, M. C. Y. Tao, and D. M. Ansley 15-F2t-isoprostane exacerbates myocardial ischemia-reperfusion injury of isolated rat hearts Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1366 - H1372. [Abstract] [Full Text] [PDF]

				Y. Wang, N. E. Kaminski, and D. H. Wang VR1-Mediated Depressor Effects During High-Salt Intake: Role of Anandamide Hypertension, October 1, 2005; 46(4): 986 - 991. [Abstract] [Full Text] [PDF]

				D. M. Pollock Endothelin, Angiotensin, and Oxidative Stress in Hypertension Hypertension, April 1, 2005; 45(4): 477 - 480. [Full Text] [PDF]

				A. A. Elmarakby, E. D. Loomis, J. S. Pollock, and D. M. Pollock NADPH Oxidase Inhibition Attenuates Oxidative Stress but Not Hypertension Produced by Chronic ET-1 Hypertension, February 1, 2005; 45(2): 283 - 287. [Abstract] [Full Text] [PDF]